Safety and efficacy of endoscopic submucosal dissection vs endoscopic mucosal resection in managing gastrointestinal tract tumors: a systematic review and meta-analysis

内镜黏膜下剥离术与内镜黏膜切除术治疗胃肠道肿瘤的安全性和有效性:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are minimally invasive alternatives to surgery for gastrointestinal tumors, differing in technique, indications, and outcomes. This meta-analysis compared the efficacy and safety of ESD vs EMR. METHODS: Following PRISMA guidelines, PubMed, Cochrane, Google Scholar, and Scopus were searched. Binary outcomes were pooled as odds ratios (ORs) and continuous outcomes as standardized mean differences (SMDs), with 95% confidence intervals (CIs), using a random-effects model. Analyses were performed in R (v4.4.1), with significance set at P < 0.05. RESULTS: Twenty-five studies with 5283 patients (2234 ESD, 3049 EMR) were included. ESD achieved higher complete resection (OR, 5.77; 95% CI, 2.18-15.26; P < 0.001; I (2) = 91%) and en bloc resection rates (OR, 13.46; 95% CI, 5.91-30.64; P < 0.001; I (2) = 82%). It required longer procedural time (SMD, 1.73; 95% CI, 1.26-2.19; P < 0.01) but had lower piecemeal resection (OR, 0.06; 95% CI, 0.01-0.38; P = 0.003). Postendoscopic resection coagulation syndrome (PECS) was more frequent with ESD (OR, 2.40; 95% CI, 1.25-4.61; P = 0.008). No significant differences were found in delayed bleeding (P = 0.06) or recurrence (P = 0.61). CONCLUSIONS: ESD provides superior complete and en bloc resection compared with EMR but involves longer procedures and higher PECS risk. Large-scale trials are needed to refine comparative outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。